Members; Officers. Immediately after the Effective Date, the Parties shall establish a joint executive committee (the "Joint Executive Committee" or "JEC"), which shall consist of six members, three members from each of the Company and BMS. The initial members of the JEC are set forth on Exhibit 2.1. Each of the Company and BMS may replace any or all of its representatives on the JEC at any time upon written notice to the other in accordance with Section 16.5 of this Agreement. Such representatives shall at all times include each such Party's [**] and most senior pharmaceutical business officer and one other senior officer of each such Party. Any member of the JEC may designate a substitute to temporarily attend and perform the functions of that member at any meeting of the JEC. The Company and BMS each may, in its discretion, invite non-member representatives of such Party to attend meetings of the JEC. The JEC shall be co-chaired by a representative of each of the Company and BMS. The co-chairpersons shall appoint a secretary of the JEC, and such secretary shall serve for such term as designated by the co-chairpersons. The initial co-chairpersons and the initial secretary are designated on Exhibit 2.1.
Appears in 3 contracts
Samples: Development, Promotion, Distribution and Supply Agreement, Development, Promotion, Distribution and Supply Agreement (Imclone Systems Inc/De), Development, Promotion, Distribution and Supply Agreement (Imclone Systems Inc/De)
Members; Officers. Immediately after the Effective Date, the Parties shall establish a joint executive committee (the "Joint Executive CommitteeJOINT EXECUTIVE COMMITTEE" or "JEC"), which shall consist of six members, three members from each of the Company and BMS. The initial members of the JEC are set forth on Exhibit EXHIBIT 2.1. Each of the Company and BMS may replace any or all of its representatives on the JEC at any time upon written notice to the other in accordance with Section 16.5 of this Agreement. Such representatives shall at all times include each such Party's [**] and most senior pharmaceutical business officer and one other senior officer of each such Party. Any member of the JEC may designate a substitute to temporarily attend and perform the functions of that member at any meeting of the JEC. The Company and BMS each may, in its discretion, invite non-member representatives of such Party to attend meetings of the JEC. The JEC shall be co-chaired by a representative of each of the Company and BMS. The co-chairpersons shall appoint a secretary of the JEC, and such secretary shall serve for such term as designated by the co-chairpersons. The initial co-chairpersons and the initial secretary are designated on Exhibit EXHIBIT 2.1.
Appears in 1 contract
Samples: Development, Promotion, Distribution and Supply Agreement (Bristol Myers Squibb Co)